MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Levodopa(L-dopa)"

  • 2019 International Congress

    Sudden alopecia secondary to levodopa treatment

    N. Garcia Alvarado, N. López Ariztegui, MI. Morales Casado, JC. Segundo Rodríguez, C. Schoendorff Ortega, R. Almansa Castillo, JA. Perez Matos, A. ávila Fernández, C. Marsal Alonso (Toledo, Spain)

    Objective: Report a rarely documented side effect of dopaminergic therapy and review the literature on this aspect, highlighting the underlying mechanisms hypothetically involved. Background: Levodopa…
  • 2019 International Congress

    Levodopa response in later stages of Parkinson’s disease: a case-control study

    M. Fabbri, M. Coelho, D. Abreu, L. Guedes, M. Rosa, A. Antonini, J. Ferreira (Lisbon, Portugal)

    Objective: To compare the response of motor and non-motor symptoms (NMS) to a L-dopa challenge test  between late stage (LS) PD patients and advanced stage…
  • 2019 International Congress

    Factors associated with dyskinesia in Parkinson’s disease in Mainland China

    X. Zhou, LF. Fang, XT. Zhou, XX. Zhou, YW. Zhao, LX. Qin, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: To identify the association between dyskinesia and related risk factors, the medication dosage range considered safe and treatment-related variables.To identify the association between dyskinesia…
  • 2019 International Congress

    Levodopa-responsive tremor in a young child as a delayed complication of osmotic demyelination from severe hypernatremia

    L. Tochen, M. Cameron, C. Brady, M. Fleming (Washington, DC, USA)

    Objective: To describe a case of levodopa responsive tremor due to osmotic demyelination as a result of severe hypernatremia Background: Osmotic demyelination is a known…
  • 2019 International Congress

    Opicapone and levodopa-carbidopa intestinal gel infusion: a cost saving analysis in the United Kingdom

    V. Leta, D. van Wamelen, A. Sauerbier, S. Jones, A. Podlewska, D. Trivedi, M. Parry, P. Odin, A. Storch, Z. Pirtošek, A. Antonini, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To investigate whether the use of Opicapone as an add-on therapy to levodopa-carbidopa intestinal gel (LCIG) infusion in advanced Parkinson’s disease (PD) reduces the…
  • 2019 International Congress

    Effect of gastrointestinal surgery on the pharmacokinetics of levodopa in Parkinson’s disease

    N. Miyaue, M. Nomoto, H. Yabe, Y. Yamanishi, S. Tada, R. Ando, M. Kubo, M. Nagai (Ehime, Japan)

    Objective: The aim of this study is to evaluate the pharmacokinetics of levodopa in patients with Parkinson’s disease (PD) who underwent gastrointestinal surgery. Background: Levodopa…
  • 2019 International Congress

    Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson’s disease

    M. Fabbri, P. Chatkaew, C. Artusi, A. Romagnolo, M. Rizzone, M. Zibetti, L. Lopiano (Turin, Italy)

    Objective: To investigate the long-term effect of levodopa-carbidopa intestinal gel (LCIG) on axial signs in Parkinson's disease (PD) patients and the related prognostic factors. Background:…
  • 2019 International Congress

    Clinical features of constipation in patients with Parkinson’s disease: a cross-sectional study in China

    LP. Zhu, XT. Zhou, Z. Zhou, LJ. Fang, XX. Zhou, YW. Zhao, LX. Qin, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: This study was designed to explore the clinical features of constipation, and investigate the risk factors of constipation in Chinese PD patients. Background: Constipation…
  • 2019 International Congress

    Levocarb-induced diplopia in idiopathic Parkinson’s disease: a case report

    S. Joza, F. Ba (Edmonton, AB, Canada)

    Objective: To present a case report of Levocarb-induced diplopia in idiopathic Parkinson’s disease. Background: Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by a…
  • 2019 International Congress

    Efficacy of Istradefylline, an A2A Receptor Antagonist, When Added to Levodopa (LD) and Other Medications for Parkinson’s Disease (PD)

    P. Lewitt, N. Hattori, A. Mori, K. Toyama, E. Ohta, P. Salzman, S. Isaacson (West Bloomfield, MI, USA)

    Objective: To evaluate the clinical effect of istradefylline as adjunctive treatment to LD in PD patients with or without additional PD medications (meds). Background: Istradefylline,…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 57
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
  • An atypical and interesting feature of Parkinson´s disease
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley